Navigation Links
Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process
Date:6/2/2008

erred provider agreement with Apria Healthcare, Inc. (NYSE: AHG), America's leading provider of integrated home healthcare products and services. Apria was awarded contracts to provide NPWT to beneficiaries in seven of the ten designated competitive bidding areas included in the first phase of the CMS competitive bidding program. With approximately 550 locations throughout the U.S., Apria serves over 2 million patients annually. The Apria/Smith & Nephew collaboration will provide a smooth transition from hospital to homecare, giving more patients access to clinically effective NPWT while reducing overall treatment costs. In addition to Apria being awarded contracts, Smith & Nephew NPWT systems will be available through existing regional providers in two further competitive bidding areas.

In addition, Smith & Nephew has been working in collaboration with Universal Hospital Services, Inc. (UHS) since October 2007, providing NPWT to the U.S. acute care and long-term care markets. The continuum of care is completed, through UHS focusing on acute care and LTACs, and Apria, along with our existing regional providers, providing NPWT to home patients upon hospital discharge.

As a global leader in wound care, Smith & Nephew is unique in that it offers a total wound management solution that includes NPWT and a comprehensive portfolio of advanced wound management products from ACTICOAT(TM) and ALLEVYN(TM) to VERSAJET(TM), along with service and education to help ensure that the right products are used at the right time on the right wounds. In addition to being FDA-cleared in the U.S., the Smith & Nephew NPWT systems are cleared for sale in Australia, Canada and South Africa as well as CE-marked for use in Europe.

For more information ab
'/>"/>

SOURCE Smith & Nephew
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
2. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
3. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
4. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
5. SmithAmundsen Elects New Partner, Linda F. Newman
6. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
7. IADR and GlaxoSmithKline Consumer Healthcare announce winners
8. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
9. Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair
10. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
11. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... , , , ... In an unprecedented and historic show of unity, advocates for all ... countries with reneging on their commitments to health by chronically underfunding programs ... health systems strengthening across the globe. , , ...
... ... Z-Folded design with antibacterial effectiveness. , ... Portland, OR (Vocus) July 21, 2009 -- HemCon Medical Technologies, ... is a next generation, z-folded hemostatic chitosan dressing, designed for battlefield and acute care ...
... , , , ... Board: PTSH) today announced that its subsidiary, Disability Access Corporation ... Inc. (DAC) has signed a $245,000 contract with Tuolumne Joint ... renewed its contract (not to exceed $120,000) with the Office ...
... , , , ... DGX ), the world,s leading provider of diagnostic testing, information and ... income from continuing operations rose to $188 million, or $1.00 per ... the second quarter of 2008. These results include a previously disclosed ...
... , , , , ... the popular nutritional juice cleanse Food & ... groundswell of requests from the Golden State by announcing today that it will ... September 7. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090721/LA49137 ...
... ... ... 2009 -- A recent study has found that post-menopausal women who underwent synthetic hormone ... 900,000 Danish women between the ages of 50 to 79 and resulted with scientists ...
Cached Medicine News:Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 2Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 3Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 4Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 5Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 6Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 7Health News:Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments 8Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 2Health News:Next-Generation Hemostatic Dressing Available for Military Emergencies 3Health News:PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 2Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 3Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 4Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 5Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 6Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 7Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 8Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 9Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 10Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 11Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 12Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 13Health News:Quest Diagnostics Reports Strong Performance in Second Quarter 2009 14Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 2Health News:BluePrintCleanse to Create a Juice Rush With Free Shipping to State of California 3Health News:New Study Finds Yet Another Link to Cancer, Synthetic Hormones 2
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... , May 12 Carrot Medical, a ... MAVIG GmbH, the leading manufacturer of medical imaging monitor ... marketing and sales channel partnership agreement. This partnership provides ... through MAVIG,s global sales channel while offering MAVIG access ...
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Antifungal Drugs: Technologies and Global Markets , ... , , , ... , An examination of the major ...
Cached Medicine Technology:Carrot Medical Partners with MAVIG GmbH 2Carrot Medical Partners with MAVIG GmbH 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 2Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 4Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 5Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 6Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 7Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 8Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 9Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 10Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 11Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 12Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 13Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 14
Ethicon, medium clip size, 10mm, rotatable take apart...
Solid phase capture sandwich ELISA assay using a microwell format....
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI...
... first compact, broad menu clinical chemistry analyzer ... treatment setting. Care givers can now perform ... than one minute of hands-on time. Complete ... to larger, expensive laboratory analyzers are available ...
Medicine Products: